The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

Clinical trial NCT02520713 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02520713
Sponsor: Dana-Farber Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Pediatric Solid Tumor

Start date: 2015-10-01
Primary completion: 2026-06-01
Enrollment: 825

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.